Previous Page  28 / 33 Next Page
Information
Show Menu
Previous Page 28 / 33 Next Page
Page Background

conferenceseries

.com

Volume 7, Issue 3 (Suppl)

J Nutr Disorders Ther, an open access journal

ISSN: 2161-0509

Page 92

JOINT EVENT

&

July 27-29, 2017 Rome, Italy

Advances in Natural Medicines Nutraceuticals & Neurocognition

14

th

International Conference on Clinical Nutrition

13

th

International Congress on

Maximizing the efficacy of the ketogenic diet nutrition medical treatment for super-refractory status

epilepticus

Yeou-mei Christiana Liu

University Avenue(Toronto), Canada

S

uper-refractory status epilepticus (SRSE) is defined as status epilepticus (SE) that continues or recurs despite 24 hours of high

dose suppressive therapy. SRSE carries very significant morbidity in the pediatric population. A retrospective chart review was

done to identify children with SRSE in our hospital. Charts were reviewed for demographic and patient factors, details of diet

administration and outcomes were noted. Eleven children (7 boys, 4 girls), aged 0.5-13.4 years (mean±SD = 8.1±3.5) with SRSE

were identified. In all cases, the diet was given via nasogastric tube. Diet ratios and calories were calculated according to patient’s

weight, age, bowel routine and concomitant treatments (steroid treatment and intubation). During the ICU admission, diets were

modified up to 4 times per patient to achieve adequate ketosis by raising ratios or restricting calories. Ratios were adjusted up to

a 5:1 (92% of daily calorie from fat) for patients with steroid therapy or insufficient ketosis. Post ICU discharge, diet ratios were

reduced, once seizure control was achieved. The KD was effective in aborting SRSE in 9 of 11 children. In these 9 children, the diet

was started between 0-34 days (mean±SD = 11.6±6.2 days) after ICU admission. They were discharged from the ICU 3-43 days

(mean±SD = 15.1±14.1) following admission. In 8 of these 9 children, urinary ketones ranged from 8 to >16 mmol/L. The remaining

children had urine ketones ranging from 4-16 mmol L-1. KD failed to control seizures in 2 patients. In these children, KD treatment

was initiated at 36 and 46 days after onset of SE. In both cases, urinary ketones fluctuated between 0.5 to >16 mmol L-1 and both

were receiving excess carbohydrates (CHO) from medications, which likely contributed to unstable ketosis. Data on longer term

KD management was available for six children. In all, diet ratios were gradually decreased as the seizures improved, to KD ratios

of 2.75:1 (86% of daily calorie from fat) to 4.25:1 (89% of daily calorie from fat). Calories were also adjusted to maintain growth.

We have demonstrated success in utilizing the KD to abort SRSE in children. Multiple diet adjustments of calories and ratios were

required to achieve stable ketosis. Difficulty in eliminating excess -CHO from IV fluids, medications and other sources are a barrier

to effective KD administration in the ICU. In this series, children who did not respond to the KD initiated the diet later in the clinical

course of SRSE. Earlier, initiation of the KD and consistent moderate to high levels of ketosis were more common among those

children in whom the SRSE was aborted. Long-term diet and seizure outcomes in this series are currently under review.

Christiana.liu@sickkids.ca

Dietary supplement–drug interactions of patients with chronic disease in community pharmacy

Chuleegone Sornsuvit, Patcharaporn Thampitak

and

Phandhadeva Tripetch

Chiang Mai University, Thailand

T

he present study is a cross-sectional descriptive study, investigating the interactions between nutritional supplements and

medications in patients with chronic illness. Data was collected by interviewing. A sample of 58 patients with chronic illness

who co-used medications for chronic disease and food supplement: 34 females (58.6%) and 24 males (41.4%), 41 out of 58 are over

60 years old (70.7%). Collecting data was done at Chiang Mai University Pharmacy, Faculty of Pharmacy, Chiang Mai University.

The findings indicated that the medications for chronic illness could be divided into following diseases of 6 groups: hypertension,

dyslipidemia, cardiovascular, diabetes, orthopedic and other chronic diseases. Obviously, the most commonly used drugs were

for 55 hypertension patients (43.6%). Of these drugs, amlodipine was the most taken by 23 patients (18.2%). There are totally

34 types of nutritional supplement divided into 2 groups: 12 vitamins and minerals, 22 natural products. Calcium was the most

common vitamin and mineral (10.6%) while fish oil was the most used natural extract (13.27%). It was found that there were 41

pairs of interactions between nutritional supplements and medications for chronic illness, and the potential interaction was at 1

pair (24.1%). Significantly, fish oil was the most potential food supplement causing drug interactions with amlodipine (8 pairs) and

enalapril (4 pairs). In conclusion, this study can help pharmacists in order to evaluate the possibility of dietary supplement – drug

interactions and giving the consumers practical advice for taking medications.

chujang@hotmail.com

J Nutr Disorders Ther 2017, 7:3(Suppl)

DOI: 10.4172/2161-0509-C1-007